ATS 2024 Final Program

Click on the session title to view the speakers

242

TUESDAY • MAY 21

P859 Blood and Crescents With Atypical Anti Neutrophil Cytoplasmic Antibody: An Unusual Presentation of Pulmonary Renal Syndrome P860 ANCA Vasculitis Presenting With Diffuse Alveolar Hemorrhage P861 Small-vessel Vasculitis Causing Diffuse Alveolar Hemorrhage in a Patient With Polymyalgia Rheumatica: A Case Report P862 Anticoagulation Administration in a Case of Diffuse Alveolar Hemorrhage With Concomitant Acute Pulmonary Embolism P863 Celiac Disease Beyond the Gut: A Case of Lane-Hamilton Syndrome P864 Hypocomplementemic Urticarial Vasculitis: A Rare Cause of Emphysema Requiring Dual-Organ Transplant P865 IgA Nephropathy: A Rare Cause of Pulmonary Renal Syndrome P866 Therapeutic Uncertainty in a Case of Pulmonary-Renal Syndrome Due to IgA Vasculitis P867 Anti-myeloperoxidase (MPO) Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis With Pulmonary Involvement Induced by Gastroenteritis With Spontaneous Remission P868 Microscopic Polyangiitis Presenting as New-onset Rheumatoid Arthritis P869 Rare Presentation of EGPA as Small Airways Disease P870 An Elderly Non-asthmatic Patient With Eosinophilic Granulomatosis With Polyangiitis P871 Unmasking Eosinophilic Granulomatosis With Polyangiitis in Severe Asthma During Exchange of Biologic Therapy P872 Tale of a Rogue Immune System: A Case Report of Life-Threatening Eosinophilic Granulomatosis With Polyangiitis P873 From Actinomyces to Granulomatosis With Polyangiitis P874 Suspect It, Treat It: Life-threatening Thoracic Manifestations in Granulomatosis With Polyangiitis P875 Initial Presentation of GPA After COVID-19: A Case Report P876 Three P’s and a Cavity: Perinuclear Anti-neutrophil Cytoplasmic Antibody (p-ANCA), Proteinase-3 (PR3) and Granulomatosis With Polyangiitis (GPA)

P877 Embolic Stroke and Interatrial Septal Aneurysm Masking the Diagnosis of Granulomatosis With Polyangiitis P878 Granulomatosis With Polyangitis: A Case of Crooked Nose P879 Atypical Presentation of Pulmonary-Renal Syndrome (PRS) Caused by Hydralazine-induced Antineutrophil Cytoplasmic Antibody Vasculitis/Lupus Overlap: A Case Report P880 Unraveling the Diagnostic Dilemma of a Pulmonary Nodule: Polyarteritis Nodosa Versus Adenosine Deaminase 2 Deficiency in a Patient With Marfanoid Habitus C34 BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P630 Safety of Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis During the Open-label Extension Period of the Phase 3 MANDARA Study P631 Three-year Follow-up of the Selection of Biologics for Severe Asthma in Japan P632 Mepolizumab Depleted Blood Eosinophils Display a Reduced Adhesion Phenotype P633 Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Mepolizumab (SASAM Study) P634 Response to Initial Biologic Therapy According to 4 Selection Algorithms in Adult Severe Asthma P635 Real-world Mepolizumab Use in Eosinophilic San Diego Convention Center Area F (Hall A-B2, Ground Level) BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

Granulomatosis With Polyangiitis (EGPA) Demonstrates Improvement in End-organ

ATS 2024 Conference Program • San Diego, CA